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Abstract
Background/purpose The origin of cholangiolocellular
carcinoma (CoCC) is still controversial. To solve this
problem, morphometric and immunohistochemical features
of CoCC were examined.
Materials and methods Cancerousducts:15CoCClesions
from 13 resected and two autopsied cases. Non-neoplastic
ducts:20 specimensof non-cancerous areas ofeight resected
CoCC cases and of 12 resected hepatocellular carcinoma
(HCC) cases. From these specimens, cholangioles, interlob-
ularductsofsmallsize(ILD-S),interlobularductsofmedium
size (ILD-M) and septal ducts were randomly selected.
Morphometry The outer and inner diameters of these
ducts were measured. Immunohistochemistry: two hepa-
tocyte markers [Hep Par 1 and a-fetoptotein (AFP)], two
cholangiocyte markers (cytokeratin CK7, CK19), a marker
for mucin (Muc1), a hepatic stem/progenitor cell marker
(c-Kit) and epithelial membrane antigen (EMA) were used.
Results Morphometry: both mean values of the outer and
inner diameters of CoCC were far larger than those of
cholangioles, and showed intermediate values between
those of ILD-S and ILD-M. Immunohistochemistry: all
ducts of CoCCs were negative for the two hepatocyte
markers and positive for CK 7. Most CoCC ducts were
positive for CK 19. Positive rate of c-Kit of cholangiole
was most remote from that of CoCC. The positive rates of
EMA in the membranous area of ducts were similarly very
high in CoCC, cholangiole and ILD-S.
Conclusion These results suggest that CoCCs may orig-
inate from ILDs.
Keywords Cholangiolocellular carcinoma  Cholangiole 
Interlobular duct  Morphometry  Immunohistochemistry
Introduction
Cholangiolocellular carcinoma (CoCC) is a unique primary
liver cancer ﬁrst reported by Steiner et al. [1]. Its histo-
logical features consist of small cancer glands resembling
cholangioles. Formerly, this tumor had been categorized as
a subtype of intrahepatic cholangiocarcinoma (ICC) [2],
but it is now considered a different entity from ICC [3, 4].
Owing to the recent progress in studies of hepatic stem or
progenitor cells, these stem/progenitor cells are thought to
exist within or around cholangioles. CoCC is now specu-
lated to originate from the cholangiole [5–7], although
Steiner et al. [1] suggested an interlobular duct origin as
well as cholangiole origin. CoCCs usually show different
clinical features and images from the common cases of ICC
[8–10]. Their images usually show mass forming type
without dilatation of peripheral bile ducts. They sometimes
develop in patients with chronic liver diseases.
In the present study, we examined the morphometric and
immunohistochemical features of CoCCs and compared
them with those of various non-neoplastic ducts [cho-
langioles, interlobular ducts (ILDs) and septal ducts] in
order to clarify the cell origin.
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Materials
A total of 15 CoCC lesions from 13 resected and two
autopsied cases were retrieved from the histopathology
ﬁles of the Teikyo University Hospital and consultation
ﬁles of the Department of Pathology of Teikyo University,
during the period of 1990–2011. As control tissue for
comparative study, 20 specimens of non-cancerous areas
consisting of eight resected CoCC cases and 12 resected
hepatocellular carcinoma (HCC) cases were also retrieved
from the same histopathology ﬁles.
Clinico-pathological data
Clinico-pathological data of the CoCC and control cases
are shown in Tables 1 and 2. The CoCC cases ranged in
age from 46 to 86 years (mean 65.1 years), and eight were
male and seven female. As to the causative factors of liver
disease, two patients were positive for hepatitis B surface
antigen (HBsAg), four for hepatitis C antibody (HCAb),
and one had alcoholic liver disease. Histological features of
non-cancerous extra-nodular liver tissue showed normal
liver in ﬁve cases, chronic hepatitis in seven cases and liver
cirrhosis in three cases. Fourteen cases had solitary tumors
and one had 3 tumors. In this study, only the largest tumors
were examined. The large diameters of these 15 tumors
ranged from 0.8 to 7.5 cm (mean 3.15 cm). Microscopi-
cally, all 15 tumors showed histological features of well-
differentiated tubular adenocarcinoma (Fig. 1).
Patientageofthecontrolcasesrangedfrom46to85 years
(mean69.7 years)(Table 2).Thirteenpatientsweremaleand
sevenwerefemale.ThreewerepositiveforHBsAgand10for
HCAb. All 20 were resected cases. Non-cancerous extra-
nodularlivertissueswerenormalliverinsevencases,chronic
hepatitis in 11 cases and liver cirrhosis in two cases.
Methods
Classiﬁcation of glands
The diagnosis of CoCC was based on the deﬁnitions
described in the newest version of WHO classiﬁcation of
tumors of the digestive system [3] and the general rules for
the clinical and pathological study of primary liver cancer
(5th edition, revised version) [4]. The non-neoplastic ducts
were classiﬁed according to the description of previous
works [11, 12].
Cholangioles: small ducts located at peripheral areas (a
little outside) of portal tracts without accompanying portal
veins and arteries (Fig. 1a, b). Interlobular ducts and septal
ducts: ducts located at the central area of portal tracts
accompanying portal veins and arteries. Ducts thinner than
100 lm were classiﬁed as ILDs (Fig. 1a–d), and those
thicker than 100 lm were classiﬁed as septal ducts
(Fig. 1e). ILDs were subclassiﬁed as ILDs of small size
(ILD-S, thinner than 40 lm) and ILDs of medium size
(ILD-M, thicker than 40 lm), according to the deﬁnition
[12, 13]. From these control specimens, 321 cholangioles,
382 ILD-Ss, 180 ILD-Ms and 82 septal ducts were ran-
domly selected. From the CoCC cases, a total of 1500 ducts
(100 ducts/case) were also randomly selected.
Morphometry
Using the image analysis software Image J (National
Institutes of Health, Bethesda, MD, USA) [13], the outer
Table 1 Clinico-pathological
data of cholangiolocellular
carcinoma cases
HBsAg Hepatitis B surface
antigen, HCAb hepatitis C
antibody, ALD alcoholic liver
disease, NL normal liver, CH
chronic hepatitis, LC liver
cirrhosis
No. of cases 15
Age 46–86 years old (mean 65.1 years)
Gender Male 8 patients, female 7 patients
Causative factors of liver diseases HBsAg 2 cases, HCAb 4 cases, ALD 1 case
Specimen Resection 13 cases, autopsy 2 cases
Non-cancerous liver tissue NL 5 cases, CH 7 cases, LC 3 cases
No. of tumors Solitary 14 cases, multiple 1 cases (3 tumors 1 case)
Tumor size 8–75 mm (mean 31.5 mm)
Cell differentiation Well differentiated tubular adenocarcinoma 15 cases
Table 2 Clinico-pathological data of control cases
No. of cases 20 (CoCC 8 cases, HCC 12 cases)
Age 46–85 years old (mean
69.7 years)
Gender Male 13 patients, female 7
patients
Causative factors of liver
diseases
HBsAg 3 case, HCAb 10 cases
Specimen Resection 20 cases
Non-cancerous liver tissue NL 7 cases, CH 11 cases, 2 cases
CoCC Cholangiolocellular carcinoma, HCC hepatocellular carci-
noma, HBsAg hepatitis B surface antigen, HCAb hepatitis C antibody,
NL normal liver, CH chronic hepatitis, LC liver cirrhosis
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123and inner diameters of these ducts were measured in the
minor axis direction on digital photographs of CK7
immunostaining (Fig. 1e). Based on the morphometric
data, sample minimum, lower quartile, mean, upper quar-
tile, and sample maximum were computed to make box-
and-whisker diagrams (boxplots) (Figs. 2, 3).
Immunohistochemistry
Tissue samples were ﬁxed with 10% formalin, embedded
in parafﬁn, and then sliced at 4 lm. In addition to hema-
toxylin-eosin (HE) staining, immunohistochemical study
was performed on parafﬁn sections with the antibodies
listed in Table 3. Two hepatocyte markers [Hep Par 1 and
a-fetoptotein (AFP)], two cholangiocyte markers (cyto-
keratin CK7, CK19), a marker for mucin (Muc1), a hepatic
stem/progenitor cell marker (c-Kit) and epithelial mem-
brane antigen (EMA) were used. In the cases showing
positive staining with Muc1, diastase digested periodic
acid-Schiff (PAS) staining and alcian blue staining were
performed. For each marker, stainability (positively or
negatively stained) was evaluated. A quantitative evalua-
tion of positive cells was not done because the cell number
within a duct was very small. Even when the case showed
only a few positive cells, it was classiﬁed as positive. Using
Fig. 1 Classiﬁcation of various
ducts. a HE stain, b–g CK7
immunostain. Bar 50 lm( a–f),
bar 200 lm( g and inset).
a Cholangioles (thin arrows),
interlobular duct (thick arrow)
and portal vein (p). b CK7
immunostain of the same
specimen as a. Cholangioles
locate at peripheral areas (a
little outside) of portal tracts
without accompanying portal
veins. An interlobular duct
(ILD) is located at the central
area of portal tracts
accompanying a portal vein.
c An interlobular duct of small
size (ILD-S) thinner than 40 lm
(arrow). d An interlobular duct
of medium size (ILD-M) thicker
than 40 lm( arrow). e A septal
duct thicker than 100 lm.
Arrows with solid line and
arrows with dashed line show
outer and inner diameters,
respectively. f Ducts of
cholangiolocellular carcinoma
(CoCC). Cancer ducts show a
tubular, cord-like, anastomosing
pattern, the so-called antler-like
pattern. g A low magniﬁcation
view of ducts of CoCC and a
septal duct (inset the same duct
as e). In comparison with the
septal duct, ducts of CoCC look
very thin
Fig. 2 Outer diameter of cholangiolocellular carcinoma ducts and
control ducts
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123c-Kit, one positive cell within a duct was sufﬁcient for
positive evaluation. Concerning EMA, stain patterns were
classiﬁed into membranous pattern and cytoplasmic pattern
based on the positive area in the duct. When both mem-
branous area and cytoplasm were positively stained, this
pattern was classiﬁed as membranous pattern because
positivity was usually more intense in the membranous
area than in the cytoplasm.
Statistical analysis
In order to compare the outer and inner diameters of var-
ious ducts, t test was used. For comparison of the positive
rates of various antibodies, chi-square test was used.
p value\0.05 was recognized as signiﬁcant.
Results
Morphometry
Outer diameter of glands of CoCC and control ducts
Range (sample minimum–sample maximum), mean, stan-
dard deviation (SD), p value in CoCC versus various duct
groups were as follows, and a boxplot is shown in Fig. 2.
Cholangiolocellular carcinoma 10.2–76.6, 31.8, 9.2 lm
Cholangiole 5.4–19.7, 13.8, 3.0 lm, p\0.0001
ILD-S 15.3–39.9, 26.5, 5.6 lm, p\0.0001
ILD-M 40.4–97.7, 65.0, 17.3 lm, p\0.0001
Septal duct 100.7–298.0, 149.9, 48.7 lm, p\0.0001
The outer diameter of CoCC was far larger than that of
cholangiole (p\0.0001). It was also signiﬁcantly larger
than that of ILD-S (p\0.0001) but signiﬁcantly smaller
than that of ILD-M (p\0.0001) (Figs. 1a–d, f, 2). It
was far smaller than that of septal duct (p\0.0001)
(Figs. 1e–g, 2).
Inner diameter of glands of cholangiolocellular carcinoma
and control ducts
Range, mean, SD, p value versus CoCC in various duct
groups were as follows, and the boxplot is shown in Fig. 3.
Cholangiolocellular carcinoma 0–60.6, 9.3, 5.9 lm
Cholangiole 0–6.1, 1.1, 1.2 lm,
p\0.0001
ILD-S 0.5–17.7, 6.5, 3.6 lm,
p\0.0001
ILD-M 4.1–62.0, 11.4, 24.7 lm,
p\0.0001
Septal duct 21.7–230.8, 76.7,
42.5 lm, p\0.0001
The inner diameter of CoCC was far larger than that of
cholangiole (p\0.0001). It was also signiﬁcantly larger
than that of ILD-S (p\0.0001). However, it was signiﬁ-
cantly smaller than that of ILD-M (p\0.0001) (Figs. 1a–
d, f, 2).
Immunohistochemistry
Hepatocyte markers: Hep Par 1 and AFP
Both Hep Par 1 and AFP were negatively stained in all
ducts of CoCC and control ducts (Table 4). CoCC and Fig. 3 Inner diameter of cholangiolocellular carcinoma ducts and
control ducts
Table 3 List of antibodies and staining reagents
Primary antibody Clone Species Reference Dilution Staining reagent
Hep Par 1 OCH1E5 Mouse DAKO, Tokyo, Japan 1:60 DAB
AFP C3 Mouse Novocastra, Newcastle, UK 1:60 DAB
CK7 OV-TL12/30 Mouse DAKO 1:60 DAB
CK19 RCK108 Mouse MP Biomedicals, Morgan Irvine, CA, USA 1:60 DAB
Muc1 Ma695 Mouse Novocastra 1:125 DAB
c-Kit Rabbit DAKO 1:125 DAB
EMA E29 Mouse DAKO 1:125 DAB
DAB Diaminobenzidene, AFP a-fetoprotein, CK cytokeratin, EMA epithelial membrane antigen
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123control ducts did not show hepatocytic character
immunohistochemically.
Cholangiocyte markers: CK7 and CK19
The cholangiocyte marker CK7 was positively stained in
all ducts of CoCC and control ducts (Table 4; Fig. 1).
CK19 was positively stained in most of the CoCC ducts
and control ducts (Table 4). The positive rate in CoCC,
cholangiole, ILD-S, ILD-M and septal ducts was 89.1,
96.0, 94.2, 97.2 and 97.6%, respectively. These results of
CK7 and CK19 showed that CoCC and control ducts have
cholangiocyte character.
Marker for mucin: Muc1
The positive rates of Muc1 in CoCC, cholangiole ILD-S,
ILD-Mandseptalductswere6.9,21.2,30.4,18.3and25.6%,
respectively(Table 4;Fig. 4).ThepositiverateinCoCCwas
signiﬁcantly lower than any control duct group (p\0.05).
Although the positive rate was low, some CoCCs did stain
positive for Muc1. The positivity was conﬁrmed by diastase
digested PAS staining and alcian blue staining (Fig. 4).
Stem/progenitor cell marker: c-Kit
c-Kit was positively stained in 1.9% of CoCC ducts
(Table 4; Fig. 5). However, cholangioles, ILD-Ss, ILD-Ms
and septal ducts also showed positivity of 47.0, 13.6, 7.8
and 4.9%, respectively (Table 4). Among control ducts, the
positive rate of cholangiole was farthest from that of
CoCC.
Epithelial membrane antigen
Epithelial membrane antigen was positively stained in
almost all CoCC ducts and in all control ducts. However,
stain patterns (membranous or cytoplasmic pattern) were
different depending on the ducts (Table 4; Fig. 6). CoCC
ducts, cholangioles and ILD-Ss showed positive rates of
membranous pattern of nearly or precisely 100%. How-
ever, thicker ducts, e.g., ILD-Ms and septal ducts, showed
lower positive rates, 12.2 and 0%, respectively.
Stain patterns of EMA of control ducts showed a close
relationship with duct size (outer diameter) (Fig. 7). Within
the range from 5 to 54.9 lm, the smaller the duct size, the
higher the positive rate of membranous pattern, and the
lower the cytoplasmic pattern (Fig. 7). A transitional zone
of stain patterns of EMA, roughly deﬁned as 30–50 lm,
and a conversion point at about 40 lm, was noted.
By contrast, the stain patterns of EMA of CoCC ducts
were membranous pattern-dominant, independent of duct
sizes (Fig. 8). In every size, the positive rate of membra-
nous pattern was higher than 90%.
Discussion
Based on the recent advances in hepatic stem/progenitor
cell research, some primary liver cancers are thought to
Table 4 Results of immunohistochemistry in cholangiolocellular carcinoma and control ducts
Hep Par1 AFP CK7 CK19 MUC1 c-Kit EMA
CoCC (n = 1500) 0 (0%) 0 (0%) 1500 (100%) 1337 (89.1%) 103 (6.9%) 29 (1.9%) 1481 (98.7%)
M: 1419 (94.6%)
C: 62 (4.1%)
Cholangiole (n = 321) 0 (0%) 0 (0%) 321 (100%) 308 (96.0%)** 68 (21.2%)* 151 (47.0%)* 321 (100%)
M: 321 (100%)*
C: 0 (0%)
ILD-S (n = 382) 0 (0%) 0 (0%) 382 (100%) 360 (94.2%)** 116 (30.4%)* 52 (13.6%)* 382 (100%)
M: 356 (93.2%)**
C: 26 (6.8%)
ILD-M (n = 180) 0 (0%) 0 (0%) 180 (100%) 175 (97.2%)** 33 (18.3%)* 14 (7.8%)* 180 (100%)
M: 22 (12.2%)*
C: 158 (87.8%)
Septal duct (n = 82) 0 (0%) 0 (0%) 82 (100%) 80 (97.6%)** 21 (25.6%)* 4 (4.9%) 82 (100%)
M: 0 (0%)*
C: 82 (100%)
CoCC Cholangiolocellular carcinoma, ILD-S interlobular duct (small), ILD-M interlobular duct (medium-sized), M membrane-positive,
C cytoplasm-positive versus cholangiolocellular carcinoma
* p\0.0001, ** p\0.05
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123originate from such cells [14]. CoCC is speculated to arise
from cholangioles, where these stem/progenitor cells exist
[5–7], and thus is now classiﬁed as a different entity from
ICC [3, 4]. However, interlobular ducts were also believed
to be the origin of CoCC, since Steiner et al. [1] initially
reported this unique tumor. In any event, the cell origin of
CoCC has been a matter of debate until now.
In order to ﬁnally settle this controversy, we performed
morphometric and immunohistochemical studies of CoCCs
as well as various non-neoplastic ducts (cholangioles,
interlobular ducts and septal ducts). We were able to obtain
some useful ﬁndings as described below.
Duct size
Precise morphometric data of CoCC as well as control
ducts were clariﬁed for the ﬁrst time in this study. Both the
outer and inner diameters of CoCC were far larger than
those of cholangioles, showing intermediate values
between those of ILD-S and ILD-M. This was an unex-
pected result, suggesting interlobular bile duct to be the
more likely origin of CoCC than cholangiole. In cases of
poorly differentiated adenocarcinoma, both cell size and
duct size may change variously. They can be far larger than
those of the original benign ducts in some cases, and they
can be far smaller in other cases. However, the well-dif-
ferentiated tubular adenocarcinomas in the present study
must not have shown extensive size alteration. According
to our morphometric study of well- and moderately-dif-
ferentiated adenocarcinoma of hepatic hilus (350 tumor
cells from ﬁve cases), the tumor cells showed almost the
same size as non-tumor cells (unpublished data). In our
Fig. 4 Immunohistochemistry
of Muc1 and alcian blue stain in
CoCC and cholangiole. a Muc1-
positive area of CoCC. Both
glandular lumina and
intracytoplasmic areas are
positive for Muc1. b Alcian blue
stain of the same area as a. Both
glandular lumina and
intracytoplasmic areas are
positive for alcian blue. c A
cholangiole positive for Muc1
in the glandular lumen. d A
cholangiole positive for Muc1
in the glandular lumen and in
the cytoplasm. e Other
cholangioles positive for alcian
blue in the glandular lumina.
Bar 50 lm( a–e)
Fig. 5 Immunohistochemistry of c-Kit in cholangioles and an ILD.
Thin arrows show c-Kit-positive cells in cholangioles. Thick arrow
shows a c-Kit-positive cell in an ILD-S. This positive cell shows
similar size and features to neighboring ILD cells except for the c-Kit
positivity. Bar 50 lm. Inset shows high magniﬁcation view of c-Kit
positive cells in cholangioles. Bar 20 lm
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123morphometric study of HCC, well-differentiated HCC cells
were smaller than non-cancerous hepatocytes [15]. In high
magniﬁcation views (Fig. 1a–d, f), the CoCC duct is appar-
ently far larger than the cholangiole, with its size appearing
similar to ILDs. In a low magniﬁcation view (Fig. 1g),
however, CoCC ducts look far thinner than septal ducts,
providing a plausible explanation for the reason why many
pathologists thought that CoCC resembles cholangiole.
Character of CoCC
All or nearly all CoCC ducts were stained negatively for
hepatocyte markers and positively for cholangiocyte mark-
ers. This result showed that CoCC had cholangiocyte char-
acterbutnothepatocyte character.Althoughthepositiverate
was low, Muc1 was positively stained in CoCC. This also
suggests the adenocarcinoma character of CoCC.
As a matter of fact, it has been believed that CoCC does
not show mucin production [3, 4]. However, cholangioles
did show mucin production in the present study. Therefore,
mucin production cannot be an exclusion item for the
diagnosis of CoCC. Because the positive rate of mucin
staining is far lower than control ducts, CoCC must have
been recognized as carcinoma without mucin.
So far, MUC1–4, 5AC, 5B, 6–8, 11–13 and 15–17 genes
codingthebackbonemucincore proteinhave beenidentiﬁed
in humans. Among these MUCs, we used MUC1 in the
present study because this antibody was proved to be well
sensitive for detecting mucin in the previous study [16]. We
also used diastase digested PAS staining and alcian blue
staining to exclude the possibility of false positive.
The positive rate of c-Kit (stem/progenitor cell marker)
was far lower than that of cholangiole. Furthermore, c-Kit
was positively stained in ILD-S, ILD-M and septal duct,
suggesting that c-Kit is not a reliable speciﬁc marker for
stem/progenitor cells. These results could not prove a stem/
progenitor character of CoCC.
Stain patterns of EMA
The positive stain of EMA in the membranous site of the
cancer duct (membranous pattern) has been recognized as a
Fig. 6 Immunohistochemistry of EMA in CoCC and control ducts.
a CoCC ducts mostly showed positive stain in the membranous areas
of the lumina (membranous pattern). b A cholangiole (thin arrow)
and an ILD-M (thick arrow) show membranous pattern. c Two ILD-
Ss show membranous pattern. d An ILD-M shows positivity in the
cytoplasm (cytoplasmic pattern). e A septal duct shows cytoplasmic
pattern. Bar 50 lm( a–d), 100 lm( e)
Fig. 7 Relationship between duct sizes and stain patterns of EMA in
control ducts
Fig. 8 Relationship between duct sizes and stain patterns of EMA in
CoCC
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123speciﬁc feature of CoCC [17]. In fact, more than 90% of
CoCC ducts showed a membranous pattern in this study.
However, this result did not necessarily support the chol-
angiole origin theory of CoCC. Among various control
ducts, not only cholangioles but also ILD-Ss and ILD-Ms
showed a membranous pattern. A transitional zone was
evident in the range of 30–50 lm, with the conversion
point from membranous to cytoplasmic pattern being
around 40 lm. These ﬁndings of the EMA staining pattern
suggest that CoCC might have arisen from cholangioles or
ILDs.
Finally, the clinical and imaging ﬁndings of CoCC
should be discussed. CoCCs are frequently associated with
chronic liver diseases. The images of CoCC usually show
mass forming type without dilatation of peripheral bile
ducts [9–11]. Such clinical and imaging ﬁndings can also
be explained by the ILD origin theory. Because an ILD is
the thinnest bile duct except for cholangioles and bile
canaliculi, a carcinoma originating from an ILD cannot
cause dilatation of peripheral bile ducts. That is why the
carcinoma shows mass forming type in images. If chronic
inﬂammation of peripheral portal tracts promotes carcino-
genesis of cholangiocytes of ILDs, the co-existence of
CoCC and chronic liver disease is reasonable.
Based on these ﬁndings and considerations, ILD is more
likely to be considered as the origin of CoCC than chol-
angiole. The results and conclusions of this study differed
from other studies. The former studies should also be
respected. Because the morphometric and immunohisto-
chemical ﬁndings may not be the direct evidence of
interlobular duct carcinoma, more detailed molecular
studies are necessary to clarify the origin of CoCC.
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